These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 9816472)

  • 21. Enhanced nitric oxide generation from nitric oxide synthases as the cause of increased peroxynitrite formation during acute restraint stress: Effects on carotid responsiveness to angiotensinergic stimuli in type-1 diabetic rats.
    Moreira JD; Pernomian L; Gomes MS; Moreira RP; do Prado AF; da Silva CH; de Oliveira AM
    Eur J Pharmacol; 2016 Jul; 783():11-22. PubMed ID: 27118175
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Influence of diabetes on cardiac nitric oxide synthase expression and activity.
    Stockklauser-Färber K; Ballhausen T; Laufer A; Rösen P
    Biochim Biophys Acta; 2000 Dec; 1535(1):10-20. PubMed ID: 11113627
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cardiovascular diseases and the nitric oxide pathway.
    Llorens S; Nava E
    Curr Vasc Pharmacol; 2003 Oct; 1(3):335-46. PubMed ID: 15320480
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Thirty Years of Saying NO: Sources, Fate, Actions, and Misfortunes of the Endothelium-Derived Vasodilator Mediator.
    Vanhoutte PM; Zhao Y; Xu A; Leung SW
    Circ Res; 2016 Jul; 119(2):375-96. PubMed ID: 27390338
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Role of oxidative stress in development of cardiovascular complications in diabetes mellitus.
    Haidara MA; Yassin HZ; Rateb M; Ammar H; Zorkani MA
    Curr Vasc Pharmacol; 2006 Jul; 4(3):215-27. PubMed ID: 16842139
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Insulin resistance and endothelial dysfunction: the road map to cardiovascular diseases.
    Cersosimo E; DeFronzo RA
    Diabetes Metab Res Rev; 2006; 22(6):423-36. PubMed ID: 16506274
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Mechanisms underlying endothelial dysfunction in diabetes mellitus.
    Hink U; Li H; Mollnau H; Oelze M; Matheis E; Hartmann M; Skatchkov M; Thaiss F; Stahl RA; Warnholtz A; Meinertz T; Griendling K; Harrison DG; Forstermann U; Munzel T
    Circ Res; 2001 Feb; 88(2):E14-22. PubMed ID: 11157681
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Normal and pathological distribution of nitric oxide in the cardiovascular system.
    Malinski T
    Pol J Pharmacol; 1998; 50(6):387-91. PubMed ID: 10385920
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Functional status of vascular endothelium in diabetes mellitus.
    Saboor M; Moinuddin ; Ajmal M; Ilyas S
    J Ayub Med Coll Abbottabad; 2014; 26(2):239-43. PubMed ID: 25603686
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Endothelial nitric oxide synthase uncoupling and perivascular adipose oxidative stress and inflammation contribute to vascular dysfunction in a rodent model of metabolic syndrome.
    Marchesi C; Ebrahimian T; Angulo O; Paradis P; Schiffrin EL
    Hypertension; 2009 Dec; 54(6):1384-92. PubMed ID: 19822799
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Tonic inhibition by G protein-coupled receptor kinase 2 of Akt/endothelial nitric-oxide synthase signaling in human vascular endothelial cells under conditions of hyperglycemia with high insulin levels.
    Taguchi K; Sakata K; Ohashi W; Imaizumi T; Imura J; Hattori Y
    J Pharmacol Exp Ther; 2014 May; 349(2):199-208. PubMed ID: 24570070
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Arginase as a potential target in the treatment of cardiovascular disease: reversal of arginine steal?
    Pernow J; Jung C
    Cardiovasc Res; 2013 Jun; 98(3):334-43. PubMed ID: 23417041
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Metabolites of flavonoid compounds preserve indices of endothelial cell nitric oxide bioavailability under glucotoxic conditions.
    Qian Y; Babu PVA; Symons JD; Jalili T
    Nutr Diabetes; 2017 Sep; 7(9):e286. PubMed ID: 28892039
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Impaired NO-dependent vasodilation in patients with Type II (non-insulin-dependent) diabetes mellitus is restored by acute administration of folate.
    van Etten RW; de Koning EJ; Verhaar MC; Gaillard CA; Rabelink TJ
    Diabetologia; 2002 Jul; 45(7):1004-10. PubMed ID: 12136399
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The physiology and pathophysiology of the nitric oxide/superoxide system.
    Münzel T; Heitzer T; Harrison DG
    Herz; 1997 Jun; 22(3):158-72. PubMed ID: 9232165
    [TBL] [Abstract][Full Text] [Related]  

  • 36. High glucose-induced tyrosine nitration in endothelial cells: role of eNOS uncoupling and aldose reductase activation.
    El-Remessy AB; Abou-Mohamed G; Caldwell RW; Caldwell RB
    Invest Ophthalmol Vis Sci; 2003 Jul; 44(7):3135-43. PubMed ID: 12824263
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Role of the decreased nitric oxide bioavailability in the vascular complications of diabetes mellitus.
    Masha A; Dinatale S; Allasia S; Martina V
    Curr Pharm Biotechnol; 2011 Sep; 12(9):1354-63. PubMed ID: 21235455
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Clinical significance of nitric oxide in hypertension].
    Naruse M; Naruse K; Yoshimoto T; Tanaka M; Tanabe A; Demura H
    Nihon Naibunpi Gakkai Zasshi; 1994 Jun; 70(5):489-502. PubMed ID: 7525365
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Reversibility of endothelial dysfunction in diabetes: role of polyphenols.
    Suganya N; Bhakkiyalakshmi E; Sarada DV; Ramkumar KM
    Br J Nutr; 2016 Jul; 116(2):223-46. PubMed ID: 27264638
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Arginase Inhibition Restores Peroxynitrite-Induced Endothelial Dysfunction via L-Arginine-Dependent Endothelial Nitric Oxide Synthase Phosphorylation.
    Nguyen MC; Park JT; Jeon YG; Jeon BH; Hoe KL; Kim YM; Lim HK; Ryoo S
    Yonsei Med J; 2016 Nov; 57(6):1329-38. PubMed ID: 27593859
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.